Y Intercept (Hong Kong) LTD United Therapeutics Corp Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $1.27 Million - $1.52 Million	5,927 Added 418.28%	7,344 $1.61 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $300,148 - $351,756	1,417 New	1,417 $320,000
Q1 2023 May 09, 2023	BUY	$212.99 - $276.17 $467,513 - $606,193	2,195 New	2,195 $491,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $560,291 - $721,473	-3,372 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $108,933 - $127,703	-591 Reduced 14.91%	3,372 $729,000
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $312,596 - $373,461	1,738 Added 78.11%	3,963 $731,000
Q2 2021 Aug 26, 2021	BUY	$170.47 - $211.93 $379,295 - $471,544	2,225 New	2,225 $399,000
Q2 2021 Aug 12, 2021	BUY	$170.47 - $211.93 $0 - $0	0 New	0 $399,000

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.